Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /homepages/23/d642040844/htdocs/Deqebat/wp-content/plugins/revslider/includes/operations.class.php on line 2364
Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /homepages/23/d642040844/htdocs/Deqebat/wp-content/plugins/revslider/includes/operations.class.php on line 2368
Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /homepages/23/d642040844/htdocs/Deqebat/wp-content/plugins/revslider/includes/output.class.php on line 3169
Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /homepages/23/d642040844/htdocs/Deqebat/wp-content/themes/Divi/includes/builder/functions.php on line 4564 GcMAF: A Suppressed Cancer Cure? – Deqebat Warning: A non-numeric value encountered in /homepages/23/d642040844/htdocs/Deqebat/wp-content/themes/Divi/functions.php on line 5837
GcMAF: A Suppressed Cancer Cure?
Nov 15, 2018 GcMAF = Gc protein-derived macrophage activating factor) is a protein produced by modification of vitamin D-binding protein.
Biochemically, GcMAF results from sequential deglycosylation of the vitamin D-binding protein (the Gc protein), which is naturally promoted by lymphocytes (B and T cells).The resulting protein may be a macrophage activating factor (MAF).MAFs are lymphokines that control the expression of antigens on the surface of macrophages, and one of their functions is to make macrophages become cytotoxicto tumors.
PLEASE JOIN ME (Ian R Crane) at Southwark Crown Court at 9.30am on Monday 19th Nov 2018, to support DAVID NOAKES, as he faces the full wrath of BIG PHARMA’s protection racket … ENFORCED by the MHRAon behalf of Big Pharma & the UK Government!
Letter from David Noakes — Nov 15, 2018
To conceal GcMAF, the body’s way of treating cancer, for another 25 years, the Medicines & Healthcare Regulatory Authority (MHRA) is prosecuting me (David Noakes) and others at Southwark Crown Court near London Bridge, at 10 am on Monday 19th November 2018.
GcMAF is a human protein, a human right, and the king of immunotherapies. It saves the lives of 75% of terminal stage 4 cancer patients, without side effects, at 1% the cost of chemotherapy. If it was put into the NHS it could save 120,000 lives a year, save the NHS £2 Billion on its drugs bill, and empty thousands of beds. It successfully treats over 50 other diseases.
We treated 11,500 people; 239 doctors chose it, and 1,400 patients around the world have submitted feedback on their excellent results with GcMAF. If you know someone who has died of cancer, they could have had a 75% chance of life if the MHRA had not concealed, and then banned, GcMAF.
There are 300 scientists behind GcMAF and 150 peer reviewed scientific research papers. Go to the American National Library of Medicine, or Pubmed, https://www.ncbi.nlm.nih.gov/pubmed/ where 70 of the papers are re-published for a second time, and key in the papers’ numbers below, or key in GcMAF. Just three are shown here:
Pubmed 12659668 in the Journal Neoplasia “GcMAF inhibits angiogenesis and tumour growth in mice,” by seven Research Institutes in Japan, Berlin, Boston and Rhode Island USA. It shows six attacks GcMAF has on cancer. That is more attacks on cancer than any other molecule.
Pubmed: 20855083 The Second is by five of Japan’s top cancer research institutes, including the prestigious Atomic Bomb Institute of Biomedical Sciences, Nagasaki. On page four you can see the picture of the tumours before treatment, and below them, tumours shrunk 90% in three weeks by GcMAF.
Pubmed 24982371 The third paper, published in the most senior of cancer scientific journals, the Anticancer Journal, is one of the 33 scientific papers written by our scientists. At the end it shows GcMAF before and after scans of patients’ tumours shrunk by 25% in a week in one of our clinics.
You can see all this online at www.gcmaf.se – press ESC and click Why Us.
Best wishes David Noakes CEO, Immuno Biotech
HUMANITY vs INSANITY – #108
‘MHRA : UK STATE EXECUTIONER‘
with David Noakes
Why are Big Pharma & the UK Government REFUSING to acknowledge EFFECTIVE CANCER TREATMENTS … and persecuting those who have PROVEN the efficacy of GcMAF?
Recorded at AV9 in May 2018 …
David Noakes was supposed to deliver this presentation but his legal team advised him to ‘stand down’ as it might be used against him in his forthcoming trial. David and his business associates have been persecuted relentlessly by the MHRA (Medicines & Healthcare Regulatory Authority), having his Bank Accounts shutdown, his business premises (including research laboratories) raided and his employees told not to return to work … all because David Noakes had developed an extremely effective CANCER treatment, which threatened the Big Pharma monopoly, established by the 1939 CANCER ACT. On the advice of his legal team, David pleaded GUILTY to manufacturing and supplying an Unlicensed Medicine and is scheduled to appear at Southwark Crown Court in Southeast London for a 3 day sentencing hearing, commencing at 10am on Monday 19th November 2018… in which the MHRA will be seeking a Custodial sentence … all because David Noakes had the audacity to produce an EFFECTIVE CANCER TREATMENT!